Related Experiment Videos

[A comparative study of 3 different types of trivalent measles-mumps-rubella vaccine]

I Contardi1, C Lusardi, G G Cattaneo

  • 1Divisione di Pediatria, Civico Ospedale di Codogno, Milano, Italia.

Insights

A new measles, mumps, and rubella (MMR) vaccine showed excellent tolerance in children. This triple vaccine demonstrated fewer side effects and fever episodes, suggesting a more attenuated measles strain.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Measles, mumps, and rubella (MMR) are common childhood viral infections.
  • Vaccination is crucial for preventing these diseases and their complications.
  • Comparative studies are essential to evaluate the safety and efficacy of different vaccine formulations.

Purpose of the Study:

  • To compare the tolerability of three different triple vaccines against measles, mumps, and rubella.
  • To assess the incidence and severity of side effects, including fever, in children receiving the vaccines.

Main Methods:

  • A randomized, double-blind, comparative clinical trial was conducted.
  • 201 children (101 males, 100 females) aged 15 months to 14 years participated.
  • Participants received one of three types of MMR triple vaccine.

Main Results:

  • The vaccine containing Edmonston-Zagreb, Rubini, and Wistar Ra 27/3 strains was well-tolerated.
  • This specific vaccine exhibited a lower incidence of side effects and fever attacks.
  • Fever was the most frequent symptom, particularly in children aged 2-5 years.

Conclusions:

  • The MMR vaccine with Edmonston-Zagreb, Rubini, and Wistar Ra 27/3 strains demonstrates superior tolerability.
  • The enhanced tolerance is likely attributed to a more attenuated measles strain.
  • This finding supports the use of this specific vaccine formulation for improved pediatric immunization outcomes.

Related Concept Videos